Cerity Partners LLC Has $8.55 Million Holdings in The Clorox Company (NYSE:CLX)

Cerity Partners LLC increased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 13.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 52,454 shares of the company's stock after acquiring an additional 6,232 shares during the period. Cerity Partners LLC's holdings in Clorox were worth $8,545,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter valued at approximately $27,000. Innealta Capital LLC bought a new position in shares of Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC boosted its stake in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after buying an additional 130 shares in the last quarter. Family Firm Inc. bought a new stake in Clorox in the second quarter valued at $31,000. Finally, Quarry LP lifted its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after acquiring an additional 114 shares during the period. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Shares of CLX stock opened at $167.34 on Wednesday. The firm has a fifty day moving average of $162.84 and a 200-day moving average of $148.88. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.71 billion, a price-to-earnings ratio of 58.31, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.35.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter in the previous year, the business posted $0.49 EPS. Clorox's revenue for the quarter was up 27.0% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.92%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio is 170.03%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on CLX shares. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft increased their price target on Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. Barclays upped their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research report on Friday, November 1st. Finally, TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and boosted their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Clorox has an average rating of "Hold" and a consensus price target of $155.00.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.